GlassScriptPhysician profile
Wensong Li
NPI 1437146743
$3,304.20
in general payments reported to CMS, 2019-2025
26 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $241 · 2021: $275 · 2022: $442 · 2023: $570 · 2024: $547 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.03 | 2022-2025 | |
| Radius Health, INC. | $313.03 | 2019-2025 | Tymlos, Binosto |
| Horizon Therapeutics Plc | $296.80 | 2019-2022 | |
| Ibsa Pharma INC. | $224.48 | 2022-2024 | Tirosint, Licart, Tirosint |
| Foundation Medicine, INC. | $216.67 | 2022-2023 | |
| Bioventus LLC | $202.52 | 2024-2025 | Gelsyn-3, Xcell, Durolane |
| Spr Therapeutics, INC | $144.59 | 2023-2024 | Sprint Pns System |
| Genentech USA, INC. | $135.00 | 2019 | |
| Si-Bone, INC. | $128.90 | 2019-2025 | |
| Kite Pharma, INC. | $125.00 | 2023 | |
| Novo Nordisk INC | $125.00 | 2019 | |
| Boston Scientific Corporation | $119.83 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Heron Therapeutics, INC. | $115.19 | 2025 | Aponvie |
| Allergan, INC. | $113.11 | 2020-2022 | |
| Nevro Corp. | $90.29 | 2019-2024 | Senza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $59.91 | 2025 | Senza |
| Medtronic, INC. | $47.34 | 2023-2024 | Intellis Adaptivestim |
| Ferring Pharmaceuticals INC. | $46.63 | 2022-2024 | Euflexxa |
| Medtronic USA, INC. | $43.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $41.52 | 2023-2024 | Ztlido |
| Pfizer INC. | $41.07 | 2024 | |
| Fidia Pharma USA INC. | $38.94 | 2023-2025 | Hymovis, Triluron |
| Zimmer Biomet Holdings, INC. | $22.67 | 2024 | Visco-3 Sodium Hyaluronate |
| Lundbeck LLC | $21.95 | 2025 | Vyepti |
| Depuy Synthes Sales INC. | $14.82 | 2024 | Orthovisc |
| Glaxosmithkline, LLC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wensong Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.